Clinical trials: Hypnotic; Sleep Disorder
Sleep Disorder, Primary Insomnia
Study of Sleep-maintenance Activity of 3 Doses of SKP-1041
SKP-1041 is a new formulation of a marketed sleeping agent called zaleplon. Zaleplon is currently available as Sonata as well as several generic formulations. Sonata and its generics induce sleep soon after ingestion.
- Trial name
- NCT00878553
- Testing
- SKP-1041 (experimental formulation of zaleplon)
- Volunteers
- 67 people
- Sponsor
- Somnus Therapeutics, Inc.
Insomnia
Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
Chronic insomnia is one of the most common health problems among Veterans and significantly impacts their health, function, and quality of life.
- Trial name
- SEDATIVE (NCT05027438)
- Testing
- Cognitive Behavioral Therapy for Insomnia, Deprescribing
- Where
- United States
- Volunteers
- 36 people
- Sponsor
- VA Office of Research and Development
Aging, Balance
Sleepiness and the Risk of Falling
The purpose of this project is to examine the impact of sleeping pills and waking up in the middle of the night on walking balance and cognitive function, to identify risk factors for falls in older adults.
- Conditions
- Aging, Balance, Sleep
- Trial name
- NCT00383357
- Testing
- zolpidem
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- National Institute on Aging (NIA)
Insomnia
Cognitive-Behavioural and Hypnotic Treatment of Chronic Primary Insomnia Among the Elderly
The present study examines the short- and long-term clinical efficacy of cognitive-behavior therapy and pharmacological treatment in patients suffering from late-life primary insomnia.
- Trial name
- NCT00295386
- Testing
- Cognitive behavior therapy (CBT), Zopiclone
- Where
- Norway
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of Bergen
Insomnia
Discontinuation of Hypnotics in Older Veterans
Sleeping medications, called hypnotics, are often prescribed for insomnia. About one-quarter of Veterans use hypnotics (or bedtime alcohol).
- Trial name
- SWITCH (NCT03511209)
- Testing
- CBTI plus taper method A, CBTI plus taper method B
- Where
- United States
- Volunteers
- 132 people
- Sponsor
- VA Office of Research and Development
Insomnia, Primary Insomnia
Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing
We want to assess whether "how and when" one takes sleep medication results in similar or different outcomes with respect to symptom relief.
- Conditions
- Insomnia, Primary Insomnia, Psychophysiologic Insomnia
- Trial name
- NCT00156533
- Testing
- Zolpidem, Sugar Pill
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- University of Rochester